Brief: Biofrontera AG Says Unit, Galenica AB Signed Exclusive License & Supply Agreement For Marketing Of Ameluz, BF-RhodoLED
07/12/2020 14:22
Dec 7 (Reuters) - Biofrontera AG B8FGn.DE :
* BIOFRONTERA AG - UNIT AND GALENICA AB, MALMÖ, SWEDEN
SIGNED
EXCLUSIVE LICENSE AND SUPPLY AGREEMENT FOR MARKETING OF AMELUZ
AND BF-RHODOLED
* BIOFRONTERA AG - LICENSE AND SUPPLY AGREEMENT FOR
MARKETING OF
AMELUZ AND BF-RHODOLED IN SWEDEN, NORWAY, DENMARK, FINLAND AND
ICELAND
* BIOFRONTERA AG - UNDER AGREEMENT BIOFRONTERA WILL SUPPLY
AMELUZ
TO GALENICA AT A TRANSFER PRICE OF 50% OF EXPECTED NET REVENUES
* BIOFRONTERA AG - BIOFRONTERA WILL BE RESPONSIBLE FOR
MARKETING
AUTHORIZATION AS WELL AS MANUFACTURING AND QUALITY CONTROL OF
AMULEZ
Source text for Eikon: ID:nGNX6LvBx8
Further company coverage: B8FGn.DE
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biofrontera AG
See all newsBrief: Biofrontera Says Co And Units Have Entered Into An Agreement With Biofrontera Inc About How To Settle Payment Obligations By Biofrontera Inc
Brief: Biofrontera AG Says Legal Dispute On Import In USA Will Result In Revised Outlook
Brief: Biofrontera AG Resolves Capital Increase From Authorized Capital
Brief: Biofrontera AG Says Plans Capital Reduction And Considers Subsequent Capital Increase From Authorized Capital
Brief: Biofrontera AG Says FY 2022 Total Revenue Amounted To EUR 25.7 Million